About Symmetry Medical (NYSE:SMA)
Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Symmetry Medical (NYSE:SMA) Frequently Asked Questions
What is Symmetry Medical's stock symbol?
Symmetry Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "SMA."
How were Symmetry Medical's earnings last quarter?
Symmetry Medical Inc. (NYSE:SMA) posted its earnings results on Thursday, October, 30th. The healthcare company reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by $0.02. The healthcare company had revenue of $95.90 million for the quarter, compared to the consensus estimate of $98.24 million. The company's revenue was up .2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.08 EPS. View Symmetry Medical's Earnings History.
Who are some of Symmetry Medical's key competitors?
Some companies that are related to Symmetry Medical include Covidien (COV), Baxter International (BAX), C R Bard (BCR), Zimmer Biomet (ZBH), Align Technology (ALGN), DENTSPLY SIRONA (XRAY), CareFusion (CFN), Steris (STE), Bio-Rad Laboratories (BIO), West Pharmaceutical Services (WST), Hill-Rom (HRC), DexCom (DXCM), Globus Medical (GMED), ICU Medical (ICUI), VWR (VWR), LivaNova (LIVN), Integra Lifesciences (IART) and Haemonetics (HAE).
Who are Symmetry Medical's key executives?
Symmetry Medical's management team includes the folowing people:
- Thomas W. Barrett, Senior Vice President and Chief Commercial Officer - OEM Solutions
- Christopher G. Cummins, Senior Vice President, Chief Manufacturing Officer - OEM Solutions (Age 44)
- Stephen Hinora Jr., Senior Vice President - Quality Assurance/Regulatory Affairs (Age 53)
How do I buy Symmetry Medical stock?
Shares of Symmetry Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Symmetry Medical?
Symmetry Medical's mailing address is 3724 N STATE ROAD 15, WARSAW, IN 46582, United States. The healthcare company can be reached via phone at +1-574-2682252.
MarketBeat Community Rating for Symmetry Medical (SMA)MarketBeat's community ratings are surveys of what our community members think about Symmetry Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Symmetry Medical (NYSE:SMA) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Symmetry Medical (NYSE:SMA) Earnings History and Estimates Chart
Symmetry Medical (NYSE SMA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/30/2014||Q3||$0.15||$0.13||$98.24 million||$95.90 million||View||Listen|
|8/4/2014||Q2||$0.12||$0.17||$98.38 million||$101.30 million||View||Listen|
|5/1/2014||Q1||$0.09||$0.09||$99.10 million||$101.30 million||View||Listen|
|2/20/2014||Q413||$0.08||$0.10||$101.50 million||$101.20 million||View||Listen|
|10/31/2013||Q313||$0.07||$0.08||$99.05 million||$98.00 million||View||Listen|
|8/1/2013||Q2 2013||$0.08||$0.09||$99.01 million||$101.90 million||View||Listen|
|5/2/2013||Q1 2013||$0.15||$0.06||$106.04 million||$98.90 million||View||Listen|
|2/21/2013||Q4 2012||$0.18||$0.17||$107.81 million||$106.60 million||View||Listen|
|11/1/2012||Q312||$0.15||$0.18||$104.33 million||$100.90 million||View||N/A|
Symmetry Medical (NYSE:SMA) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Symmetry Medical (NYSE:SMA)
No dividend announcements for this company have been tracked by MarketBeat.com
Symmetry Medical (NYSE SMA) News Headlines
Symmetry Medical (NYSE:SMA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Symmetry Medical (NYSE:SMA) Income Statement, Balance Sheet and Cash Flow Statement
Symmetry Medical (NYSE SMA) Stock Chart for Wednesday, February, 21, 2018